Item 2.02 - Results of Operations and Financial Condition: Nutanix issued a press release on August 26, 2026 announcing financial results for its fourth fiscal quarter and fiscal year ended July 31, 2026. Fourth Quarter and Fiscal Year 2026 Performance: The company reported 16% year-over-year ARR (Annual Recurring Revenue) growth, strong free cash flow generation, and outperformance across all…

Our analysis rates this filing CAUTIOUS. Nutanix presents a mixed picture that warrants elevated caution. The company delivered strong absolute Q4 results with 16% ARR growth and impressive operating leverage (260+ bps margin expansion), supported by solid free cash flow generation. However,…

Concern level: ELEVATED (5.8/10). Key factors: Gross margin compression of 120 bps in Q4 (GAAP: 86.0%) and 60 bps full-year (Non-GAAP: 87.7%) despite 16% revenue growth signals cost pressures or unfavorable product mix that may persist; Revenue growth deceleration: Full-year 12% growth significantly lags Q4's 16% and ARR growth of 16%, indicating earlier quarters were materially weaker and…

Notable risk changes: Gross margin compression of 120 bps in Q4 FY2026 despite strong revenue growth - indicates potential cost inflation, unfavorable mix shift, or pricing pressure that could persist; Revenue growth deceleration to 12% full-year vs 16% ARR growth creates disconnect - suggests challenges in converting subscription ARR to recognized revenue or timing headwinds; FY2027 guidance implies 11.6-13.3%…

Q4 delivered 'outperformance across all fourth quarter guided metrics' (specific guidance metrics not disclosed in this filing); Non-GAAP Operating Income Q4: $198.0M (up $78.5M or 66% YoY); GAAP Operating Income Q4: $70.0M (up $38.8M or 124% YoY).

The model predicts NTNX will outperform the S&P 500 by about 0.0% over 30 days (model confidence 50%). This is model analysis for research, not investment advice.